1. Academic Validation
  2. DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase

DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase

  • Nat Commun. 2020 Mar 6;11(1):1251. doi: 10.1038/s41467-020-15109-y.
Ji Cao  # 1 Xiaobing Chen  # 1 Li Jiang 1 Bin Lu 1 Meng Yuan 1 Difeng Zhu 1 Hong Zhu 1 Qiaojun He 1 Bo Yang 1 Meidan Ying 2
Affiliations

Affiliations

  • 1 Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • 2 Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. mying@zju.edu.cn.
  • # Contributed equally.
Abstract

Ferroptosis is a newly characterized form of regulated cell death mediated by iron-dependent accumulation of lipid Reactive Oxygen Species and holds great potential for Cancer therapy. However, the molecular mechanisms underlying Ferroptosis remain largely elusive. In this study, we define an integrative role of DJ-1 in Ferroptosis. Inhibition of DJ-1 potently enhances the sensitivity of tumor cells to Ferroptosis inducers both in vitro and in vivo. Metabolic analysis and metabolite rescue assay reveal that DJ-1 depletion inhibits the transsulfuration pathway by disrupting the formation of the S-adenosyl homocysteine hydrolase tetramer and impairing its activity. Consequently, more Ferroptosis is induced when homocysteine generation is decreased, which might be the only source of glutathione biosynthesis when cystine uptake is blocked. Thus, our findings show that DJ-1 determines the response of Cancer cells to Ferroptosis, and highlight a candidate therapeutic target to potentially improve the effect of ferroptosis-based antitumor therapy.

Figures
Products
Inhibitors & Agonists
Other Products